Eyenovia announces positive study results demonstrating that its optejet® delivery technology reduces conjunctival cell toxicity from preserved ophthalmic solutions to a level comparable with non-preserved solutions

Study conducted with tufts medical center represents a breakthrough showing that microdose array print (map™) technology can provide similar benefits of non-preserved medications study conducted with tufts medical center represents a breakthrough showing that microdose array print (map™) technology can provide similar benefits of non-preserved medications
EYEN Ratings Summary
EYEN Quant Ranking